No easy choices for investors looking to buck the herd with contrarian funds
By John Waggoner
Investing involves risk, including loss of principal. Investments in international markets present special risks including currency fluctuation, the potential for diplomatic and political instability, regulatory and liquidity risks, foreign taxation and differences in auditing and other financial standards.
The views and opinions expressed in this material are those of the participants. There is no guarantee that any opinions in this material will be realized. Information should not be construed as investment advice nor be considered a recommendation to buy, sell or hold any particular security.
You should carefully consider the investment objectives, potential risks, management fees, and charges and expenses of the Fund before investing. The Fund’s prospectus contains this and other information about the Fund, and should be read carefully before investing. You may obtain a current copy of the Fund’s prospectus by calling 1-800-470-1029. Distributed by Unified Financial Securities, LLC. (Member FINRA)
The following securities were mentioned in the article. As of 6/30/2016 the fund had no position in the following securities: FCNTX, LHVAX, JACNX, SMGIX, MVALX, FMIVX, HDPCX, AIG, FITB, HBAN, CACB, FB, GE..
The Fund’s average annual returns for the following periods as of 6/30/16 are: 1 year -2.12%, 5 years 4.18%, and since inception on 12/8/06 6.03%. Performance data represents past performance and does not guarantee future results. The investment return and principal value of an investment will fluctuate. An investor’s shares, when redeemed, may be worth more or less than their original cost. Current performance of the fund may be lower or higher than the performance quoted. Data current to the most recent month end is available by calling us toll free at 1-800-470-1029.
Appleseed Fund has contractually agreed to limit the net expense rate to 1.14% of net assets of Investor shares through January 31, 2017. The gross expense ratio is 1.41%, and the net expense ratio after contractual fee waivers is 1.24%. The Fund’s ninety day redemption fee is 2.00%.